Spyre Therapeutics Revenue

Biotechnology Research • Waltham, Massachusetts, United States • 51-100 Employees

Spyre Therapeutics revenue & valuation

Annual revenue	$886,000
Revenue per employee	$10,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,900,000
Total funding	$560,000,000

Key Contacts at Spyre Therapeutics

Carlos Seminario

Senior Medical Director Clinical Development

Meme Thornton

Senior Director, Talent Acquisition

Mark Flowers

Director Program Management

Elisabeth Kurkimilis

Executive Director, Clinical Operations

Preeyam Patel

Director, Translational Sciences

Srividya Suryanarayana

Director - Analytical Development/Quality Control

David Giles

Executive Director, Corporate Strategy

Michele Snyder

Senior Director, Clinical Operations

Jennifer De Luca

Associate Director, Administration And Operations

Mariah Cornish

Director, Cmc Regulatory Affairs

Company overview

Headquarters	Waltham, Massachusetts, United States
Phone number	+16176515940
Website	spyre.com
NAICS	541714
SIC	737
Founded	2023
Employees	51-100
Socials

Spyre Therapeutics Email Formats

Spyre Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@spyre.com), used 59.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@spyre.com	61.7%
{first name}.{last name}	john.doe@spyre.com	36.2%
{first initial}.{first initial}	j.j@spyre.com	2.1%

About Spyre Therapeutics

Spyre Therapeutics is a clinical-stage biotechnology company that aims to create next-generation inflammatory bowel disease (IBD) and other immune-mediated disease products by combining best-in-class antibody engineering, dose optimization, and rational therapeutic combinations. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Vice President

Manager

Employees by Department

Spyre Therapeutics has 45 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Spyre Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2024-01-07	14	$180,000,000
2024-04-18	14	$180,000,000
2024-12-18	14	$200,000,000

Funding Insights

$560,000,000

Total funding amount

$200,000,000

Most recent funding amount

Number of funding rounds

Spyre Therapeutics Tech Stack

Discover the technologies and tools that power Spyre Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

GoDaddy

Hosting

HSTS

Security

React

JavaScript frameworks

Sanity

CMS

PWA

Miscellaneous

Netlify

CDN

Gatsby

JavaScript frameworks

Webpack

Miscellaneous

Frequently asked questions

Spyre Therapeutics is located in Waltham, Massachusetts, US.

You can reach Spyre Therapeutics at +16176515940.

Spyre Therapeutics generates an estimated annual revenue of $886,000. This revenue figure reflects the company's market position and business performance in its industry.

Spyre Therapeutics has an estimated valuation of $2,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Spyre Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Spyre Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Spyre Therapeutics has raised a total of $560,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.